Rigel Pharmaceuticals regains rights as Lilly terminates license deal
Go back to Rigel Pharmaceuticals regains rights as Lilly terminates license deal| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1149.36 -10.24 (0.88%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1159.60 | 52 Week High | $88.16 | |||
| Open | $1150.61 | 52 Week Low | $67.88 | |||
| Day High | $1158.44 | P/E | 266.06 | |||
| Day Low | $1138.31 | EPS | $4.32 | |||
| Volume | 2,220,270 | |||||
| Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) | Delayed: 48.67 +0.17 (0.35%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $48.50 | 52 Week High | $4.38 | |||
| Open | $48.04 | 52 Week Low | $1.88 | |||
| Day High | $48.87 | P/E | N/A | |||
| Day Low | $47.77 | EPS | $-1.12 | |||
| Volume | 104,968 | |||||

